Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation-Reference-Cited by-同舟云学术

Altered cytochrome 2E1 and 3A P450‐dependent drug metabolism in advanced ovarian cancer correlates to tumour‐associated inflammation

Published:2019-08-05 Issue:18 Volume:176 Page:3712-3722
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Trousil Sebastian¹,Lee Patrizia¹,Edwards Robert J.²,Maslen Lynn¹,Lozan‐Kuehne Jingky P.¹^ORCID,Ramaswami Ramya¹,Aboagye Eric O.¹,Clarke Stephen³,Liddle Christopher⁴,Sharma Rohini¹^ORCID

Affiliation:

1. Department of Surgery and CancerImperial College London London UK

2. Division of Experimental MedicineImperial College London London UK

3. Department of Medical OncologyRoyal North Shore Hospital St Leonards NSW Australia

4. Storr Liver Unit, Westmead Millennium InstituteUniversity of Sydney, Westmead Westmead NSW Australia

Funder

Cancer Institute NSW

Publisher

Wiley

Subject

Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bph.14776

Reference59 articles.

1. Cytokines down‐regulate expression of major cytochrome P‐450 enzymes in adult human hepatocytes in primary culture;Abdel‐Razzak Z.;Molecular Pharmacology,1993

2. Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes

3. REGULATION OF DRUG-METABOLIZING ENZYMES AND TRANSPORTERS IN INFLAMMATION

4. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Nuclear hormone receptors

5. THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Berberis vulgaris, and its active constituent berberine on cytochrome P450: a review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-08-14

2. Cross-species variability in lobular geometry and cytochrome P450 hepatic zonation: insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4;Frontiers in Pharmacology;2024-05-16

3. Targeting Cytochrome P450 Enzymes in Ovarian Cancers: New Approaches to Tumor-Selective Intervention;Biomedicines;2023-10-26

4. Mirvetuximab soravtansine in ovarian cancer therapy: expert opinion on pharmacological considerations;Cancer Chemotherapy and Pharmacology;2023-08-18

5. Identification of Cytochrome P450 2E1 as a Novel Target in Glioma and Development of Its Inhibitor as an Anti‐Tumor Agent;Advanced Science;2023-06-07